Tito C, Masciarelli S, Colotti G, Fazi F
J Biomed Sci. 2025; 32(1):24.
PMID: 39966897
PMC: 11837477.
DOI: 10.1186/s12929-025-01119-9.
Pepin A, Jazwiec P, Dumeaux V, Sloboda D, Kimmins S
Elife. 2024; 13.
PMID: 39612469
PMC: 11717366.
DOI: 10.7554/eLife.83288.
Liu H, Lin J, Phan Q, Bruno V, Filler S
mBio. 2024; 15(12):e0267124.
PMID: 39475281
PMC: 11633379.
DOI: 10.1128/mbio.02671-24.
Simonin P, Guerrero G, Bardin S, Gannavarapu R, Krndija D, Boyd J
Development. 2024; 151(21).
PMID: 39431301
PMC: 11529276.
DOI: 10.1242/dev.203038.
Liu H, Lin J, Phan Q, Bruno V, Filler S
bioRxiv. 2024; .
PMID: 39314401
PMC: 11419056.
DOI: 10.1101/2024.09.10.612305.
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
Tawengi M, Al-Dali Y, Tawengi A, Benter I, Akhtar S
Front Pharmacol. 2024; 15:1394997.
PMID: 39234105
PMC: 11373609.
DOI: 10.3389/fphar.2024.1394997.
Transplantation of human endometrial perivascular stem cells with hydroxy saffron yellow A promotes uterine repair in rats.
Li N, Mao J, Wang M, Qi J, Jiang Z, Li Y
Stem Cell Res Ther. 2024; 15(1):217.
PMID: 39020406
PMC: 11256499.
DOI: 10.1186/s13287-024-03821-1.
Crosstalk of MAP3K1 and EGFR signaling mediates gene-environment interactions that block developmental tissue closure.
Wang J, Xiao B, Kimura E, Mongan M, Hsu W, Medvedovic M
J Biol Chem. 2024; 300(7):107486.
PMID: 38897570
PMC: 11294703.
DOI: 10.1016/j.jbc.2024.107486.
Urinary Epidermal Growth Factor Level as a Noninvasive Indicator of Tubular Repair in Patients with Acute Kidney Injury.
Ono K, Maeshima A, Nagayama I, Kubo T, Yagisawa T, Nagata D
Diagnostics (Basel). 2024; 14(9).
PMID: 38732362
PMC: 11083164.
DOI: 10.3390/diagnostics14090947.
Vitamin A resolves lineage plasticity to orchestrate stem cell lineage choices.
Tierney M, Polak L, Yang Y, Abdusselamoglu M, Baek I, Stewart K
Science. 2024; 383(6687):eadi7342.
PMID: 38452090
PMC: 11177320.
DOI: 10.1126/science.adi7342.
Progress in Glioma Stem Cell Research.
Ramar V, Guo S, Hudson B, Liu M
Cancers (Basel). 2024; 16(1).
PMID: 38201528
PMC: 10778204.
DOI: 10.3390/cancers16010102.
Busting the Breast Cancer with AstraZeneca's Gefitinib.
Chemmalar S, Intan Shameha A, Abdullah C, Ab Razak N, Mohamad Yusof L, Ajat M
Adv Pharmacol Pharm Sci. 2023; 2023:8127695.
PMID: 38090376
PMC: 10713255.
DOI: 10.1155/2023/8127695.
Role of EGFR and FASN in breast cancer progression.
Chaturvedi S, Biswas M, Sadhukhan S, Sonawane A
J Cell Commun Signal. 2023; 17(4):1249-1282.
PMID: 37490191
PMC: 10713975.
DOI: 10.1007/s12079-023-00771-w.
Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor.
Zhang Y
Pharmacol Rev. 2023; 75(6):1218-1232.
PMID: 37339882
PMC: 10595022.
DOI: 10.1124/pharmrev.123.000906.
Neural induction drives body axis formation during embryogenesis, but a neural induction-like process drives tumorigenesis in postnatal animals.
Cao Y
Front Cell Dev Biol. 2023; 11:1092667.
PMID: 37228646
PMC: 10203556.
DOI: 10.3389/fcell.2023.1092667.
Bulk and mosaic deletions of reveal regionally defined gliogenesis in the developing mouse forebrain.
Zhang X, Xiao G, Johnson C, Cai Y, Horowitz Z, Mennicke C
iScience. 2023; 26(3):106242.
PMID: 36915679
PMC: 10006693.
DOI: 10.1016/j.isci.2023.106242.
The role of amphiregulin in ovarian function and disease.
Fang L, Sun Y, Cheng J
Cell Mol Life Sci. 2023; 80(3):60.
PMID: 36749397
PMC: 11071807.
DOI: 10.1007/s00018-023-04709-8.
Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
Papadakos K, Ekstrom A, Slipek P, Skourti E, Reid S, Pietras K
J Exp Clin Cancer Res. 2022; 41(1):363.
PMID: 36578014
PMC: 9798675.
DOI: 10.1186/s13046-022-02565-1.
A reference human induced pluripotent stem cell line for large-scale collaborative studies.
Pantazis C, Yang A, Lara E, McDonough J, Blauwendraat C, Peng L
Cell Stem Cell. 2022; 29(12):1685-1702.e22.
PMID: 36459969
PMC: 9782786.
DOI: 10.1016/j.stem.2022.11.004.
A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineering.
Liu X, Tian X, Hao X, Zhang H, Wang K, Wei Z
Mol Ther Oncolytics. 2022; 27:256-269.
PMID: 36458200
PMC: 9703009.
DOI: 10.1016/j.omto.2022.11.001.